Core Insights - fuboTV Inc. reported a quarterly loss of $0.05 per share, which was worse than the Zacks Consensus Estimate of $0.03, marking a significant earnings surprise of -300.00% [1] - The company generated revenues of $1.55 billion for the quarter ended December 2025, exceeding the Zacks Consensus Estimate by 13.46% and showing substantial growth from $443.28 million year-over-year [2] - fuboTV shares have declined approximately 9.9% since the beginning of the year, contrasting with the S&P 500's gain of 1.9% [3] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is $0.01 on revenues of $1.6 billion, while for the current fiscal year, the estimate is $0.17 on revenues of $6.29 billion [7] - The estimate revisions trend for fuboTV was mixed prior to the earnings release, resulting in a Zacks Rank 3 (Hold), indicating expected performance in line with the market [6] Industry Context - The Broadcast Radio and Television industry, to which fuboTV belongs, is currently ranked in the top 26% of over 250 Zacks industries, suggesting a favorable outlook compared to lower-ranked industries [8] - Another company in the same industry, Warner Bros. Discovery, is expected to report quarterly earnings of $0.08 per share, reflecting a year-over-year increase of 140%, although its consensus EPS estimate has been revised down by 61.7% over the last 30 days [9]

Company Overview - Opera Limited's shares increased by 13.5% to close at $14.1, following a period of 12.7% loss over the past four weeks, indicating a significant rebound in stock performance [1] - The company is benefiting from its products, including Opera Neon and Agentic AI, along with an expansion of Minipay Wallet and raised financial guidance [1] Earnings Expectations - Opera Limited is expected to report quarterly earnings of $0.33 per share, reflecting a year-over-year increase of 3.1% [2] - Revenue projections for the upcoming quarter stand at $165 million, which is a 13.2% increase compared to the same quarter last year [2] Stock Performance Insights - The consensus EPS estimate for Opera has remained unchanged over the last 30 days, suggesting that stock price movements may not sustain without trends in earnings estimate revisions [3] - The stock currently holds a Zacks Rank of 3 (Hold), indicating a neutral outlook [3] Industry Context - Opera Limited is part of the Zacks Internet - Content industry, which includes other companies like Shutterstock [3] - Shutterstock's consensus EPS estimate for its upcoming report is $1.05, representing a significant year-over-year increase of 56.7%, and it currently holds a Zacks Rank of 2 (Buy) [4]

分组1 - Madison Square Garden Entertainment (MSGE) reported quarterly earnings of $1.94 per share, missing the Zacks Consensus Estimate of $2.35 per share, but showing an increase from $1.56 per share a year ago, resulting in an earnings surprise of -17.45% [1] - The company posted revenues of $459.94 million for the quarter ended December 2025, surpassing the Zacks Consensus Estimate by 2.17%, compared to year-ago revenues of $407.42 million, and has topped consensus revenue estimates three times over the last four quarters [2] - MSG Entertainment shares have increased by approximately 14.9% since the beginning of the year, outperforming the S&P 500's gain of 1.9% [3] 分组2 - The earnings outlook for MSG Entertainment is mixed, with the current consensus EPS estimate for the coming quarter at $0.31 on revenues of $244.64 million, and $1.69 on $1.01 billion in revenues for the current fiscal year [7] - The Zacks Industry Rank indicates that Media Conglomerates is currently in the bottom 34% of over 250 Zacks industries, suggesting that the industry outlook can significantly impact stock performance [8] - Another company in the same industry, Liberty Media Corporation - Liberty Formula One Series C, is expected to report quarterly earnings of $0.47 per share, reflecting a year-over-year change of +145.6%, with revenues anticipated to be $1.54 billion, up 44.2% from the year-ago quarter [9][10]

Core Insights - J&J Snack Foods (JJSF) reported quarterly earnings of $0.33 per share, exceeding the Zacks Consensus Estimate of $0.32 per share, with an earnings surprise of +3.13% [1] - The company posted revenues of $343.78 million for the quarter ended December 2025, missing the Zacks Consensus Estimate by 1.78%, compared to $362.6 million in the same quarter last year [2] - J&J Snack Foods shares have increased by approximately 5.3% year-to-date, outperforming the S&P 500's gain of 1.9% [3] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is $0.35 on revenues of $360 million, while for the current fiscal year, the estimate is $4.46 on revenues of $1.61 billion [7] - The estimate revisions trend for J&J Snack Foods was favorable ahead of the earnings release, resulting in a Zacks Rank 2 (Buy) for the stock, indicating expected outperformance in the near future [6] Industry Context - The Food - Miscellaneous industry, to which J&J Snack Foods belongs, is currently ranked in the bottom 24% of over 250 Zacks industries, suggesting potential challenges for stock performance [8] - Another company in the same industry, Kraft Heinz, is expected to report a quarterly earnings decline of -27.4% with revenues projected at $6.42 billion, down 2.4% from the previous year [9][10]

分组1 - Hamilton Lane reported quarterly earnings of $1.55 per share, exceeding the Zacks Consensus Estimate of $1.28 per share, and showing an increase from $1.25 per share a year ago, resulting in an earnings surprise of +21.41% [1] - The company achieved revenues of $198.59 million for the quarter ended December 2025, surpassing the Zacks Consensus Estimate by 2.92%, and up from $168.26 million in the same quarter last year [2] - Hamilton Lane has consistently outperformed consensus EPS and revenue estimates over the last four quarters [2] 分组2 - The stock has gained approximately 5.3% since the beginning of the year, outperforming the S&P 500, which has gained 1.9% [3] - The current consensus EPS estimate for the upcoming quarter is $1.36 on revenues of $197.42 million, and for the current fiscal year, it is $5.46 on revenues of $771.44 million [7] - The Zacks Industry Rank for Financial - Investment Management is currently in the bottom 33% of over 250 Zacks industries, indicating potential challenges for stocks in this sector [8]

Core Insights - Pentair plc (PNR) reported quarterly earnings of $1.18 per share, exceeding the Zacks Consensus Estimate of $1.17 per share, and up from $1.08 per share a year ago, representing an earnings surprise of +1.14% [1] - The company achieved revenues of $1.02 billion for the quarter ended December 2025, surpassing the Zacks Consensus Estimate by 1.60%, compared to $972.9 million in the same quarter last year [2] Earnings Performance - Over the last four quarters, Pentair has consistently surpassed consensus EPS estimates [2] - The company had a previous quarter earnings surprise of +5.08%, with actual earnings of $1.24 per share against an expectation of $1.18 per share [1] Future Outlook - The current consensus EPS estimate for the upcoming quarter is $1.22 on revenues of $1.05 billion, and for the current fiscal year, it is $5.38 on revenues of $4.34 billion [7] - The estimate revisions trend for Pentair was mixed ahead of the earnings release, resulting in a Zacks Rank 3 (Hold), indicating expected performance in line with the market [6] Industry Context - Pentair operates within the Zacks Waste Removal Services industry, which is currently ranked in the bottom 30% of over 250 Zacks industries, suggesting potential challenges ahead [8] - The performance of Pentair's stock may be influenced by the overall outlook of the waste removal industry [8]

Core Viewpoint - PJT Partners reported quarterly earnings of $2.55 per share, exceeding the Zacks Consensus Estimate of $2.41 per share, and showing an increase from $1.90 per share a year ago, indicating a positive earnings surprise of +5.81% [1] Financial Performance - The company achieved revenues of $535.16 million for the quarter ended December 2025, which fell short of the Zacks Consensus Estimate by 2.34%, but represented an increase from $477.28 million in the same quarter last year [2] - Over the last four quarters, PJT Partners has surpassed consensus EPS estimates four times and topped consensus revenue estimates three times [2] Stock Performance - PJT Partners shares have increased approximately 4.1% since the beginning of the year, outperforming the S&P 500's gain of 1.9% [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating expected performance in line with the market in the near future [6] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is $1.34 on revenues of $377 million, while the estimate for the current fiscal year is $8.00 on revenues of $1.94 billion [7] - The trend of earnings estimate revisions for PJT Partners was mixed ahead of the earnings release, which may change following the recent report [6] Industry Context - The Financial - Miscellaneous Services industry, to which PJT Partners belongs, is currently ranked in the top 36% of over 250 Zacks industries, suggesting a favorable outlook compared to lower-ranked industries [8]

分组1 - Pfizer reported quarterly earnings of $0.66 per share, exceeding the Zacks Consensus Estimate of $0.57 per share, and showing an increase from $0.63 per share a year ago, resulting in an earnings surprise of +16.81% [1] - The company achieved revenues of $17.56 billion for the quarter ended December 2025, surpassing the Zacks Consensus Estimate by 4.26%, although this represents a decline from year-ago revenues of $17.76 billion [2] - Pfizer has surpassed consensus EPS estimates in all four of the last quarters and has topped consensus revenue estimates three times during the same period [2] 分组2 - The stock has gained approximately 7.1% since the beginning of the year, outperforming the S&P 500, which has gained 1.9% [3] - The future performance of Pfizer's stock will largely depend on management's commentary during the earnings call and the outlook for earnings estimates [3][4] - The current consensus EPS estimate for the upcoming quarter is $0.75 on revenues of $13.9 billion, and for the current fiscal year, it is $2.97 on revenues of $60.81 billion [7] 分组3 - The Large Cap Pharmaceuticals industry, to which Pfizer belongs, is currently ranked in the bottom 23% of over 250 Zacks industries, indicating potential challenges for stock performance [8] - The Zacks Rank for Pfizer is currently 5 (Strong Sell), suggesting that the stock is expected to underperform the market in the near future [6]

分组1 - Capri Holdings reported quarterly earnings of $0.81 per share, exceeding the Zacks Consensus Estimate of $0.78 per share, and up from $0.45 per share a year ago, representing an earnings surprise of +4.11% [1] - The company posted revenues of $1.03 billion for the quarter ended December 2025, surpassing the Zacks Consensus Estimate by 2.68%, but down from $1.26 billion year-over-year [2] - Capri Holdings has surpassed consensus revenue estimates four times over the last four quarters [2] 分组2 - The stock has underperformed the market, losing about 5.2% since the beginning of the year compared to the S&P 500's gain of 1.9% [3] - The company's earnings outlook is crucial for investors, with current consensus EPS estimates of $0.15 on $797.32 million in revenues for the coming quarter and $1.39 on $3.45 billion in revenues for the current fiscal year [7] - The Zacks Industry Rank for Retail - Apparel and Shoes is currently in the top 19% of over 250 Zacks industries, indicating a favorable outlook for the sector [8]

Core Insights - Merck reported quarterly earnings of $2.04 per share, exceeding the Zacks Consensus Estimate of $2.03 per share, and showing an increase from $1.72 per share a year ago, resulting in an earnings surprise of +0.62% [1] - The company achieved revenues of $16.4 billion for the quarter ended December 2025, surpassing the Zacks Consensus Estimate by 1.33% and up from $15.62 billion year-over-year [2] - Merck's stock has increased by approximately 7.7% since the beginning of the year, outperforming the S&P 500's gain of 1.9% [3] Earnings Outlook - The future performance of Merck's stock will largely depend on management's commentary during the earnings call and the company's earnings outlook [4] - The current consensus EPS estimate for the upcoming quarter is $0.32 on revenues of $16.13 billion, and for the current fiscal year, it is $6.20 on revenues of $67.36 billion [7] Estimate Revisions - Prior to the earnings release, the estimate revisions trend for Merck was unfavorable, resulting in a Zacks Rank 4 (Sell) for the stock, indicating expected underperformance in the near future [6] - Empirical research indicates a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can be tracked by investors [5] Industry Context - The Large Cap Pharmaceuticals industry, to which Merck belongs, is currently ranked in the bottom 23% of over 250 Zacks industries, suggesting potential challenges ahead [8] - Another company in the same industry, Eli Lilly, is expected to report quarterly earnings of $6.99 per share, reflecting a year-over-year increase of +31.4%, with revenues projected at $17.87 billion, up 32.1% from the previous year [9][10]